Amsalog
Alternative Names: Asulacrine; Asulacrine isethionate; CI 921; NSC 343499; SN 21407Latest Information Update: 02 Jul 1999
At a glance
- Originator Auckland Cancer Society Research Centre
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Cytostatics; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 02 Jul 1999 Discontinued-II for Cancer in New Zealand (IV-infusion)
- 02 Jul 1999 Discontinued-II for Cancer in USA (IV-infusion)
- 18 Jun 1999 Discontinued-I for Cancer in United Kingdom (IV-infusion)